US 2023/0141868 A1 · MICROORGANISM FOR IMPROVING LIVER FUNCTION OR INHIBITING FAT ACCUMULATION, AND USES OF SAME

Abstract

Provided are a microorganism selected from the group consisting of Lactobacillus salivarius LMT15-14 (Accession No. KCTC14142BP) and Lactobacillus plantarum LMT19-1 (Accession No. KCTC14141BP) or a combination thereof or a culture or extract thereof, and a use thereof.

Claims8

Dependent claims

Lactobacillus salivarius LMT15-14 (Accession No. KCTC14142BP) having activity of inhibiting triglycerides, promoting fat oxidation, and inhibiting liposynthesis.

Dependencies are inferred from the claim text.

Facts

Application

17/913,505Filed 17 Nov 2020

Priority

KR 10-2020-003590024 Mar 2020

Published

11 May 2023

Term ends

Not estimatedThe source records don’t support an estimate.

Classification14 codes

A61K 35/747
Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs: lactobacilli, e.g. L. acidophilus or L. brevis
A23L 33/135
Using additives: bacteria or derivatives thereof, e.g. probiotics
A61P 1/16
Drugs for disorders of the alimentary tract or the digestive system: for liver or gallbladder disorders, e.g. hepatoprotective agents,…
C12N 1/20
Microorganisms; Compositions thereof ; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of…:…

Abstract

Claims8

Dependent claims

Lactobacillus salivarius LMT15-14 (Accession No. KCTC14142BP) having activity of inhibiting triglycerides, promoting fat oxidation, and inhibiting liposynthesis.

Dependencies are inferred from the claim text.

Microorganism for improving liver function or inhibiting fat accumulation, and uses of same

Life of this patent

Abstract

Claims8

Microorganism for improving liver function or inhibiting fat accumulation, and uses of same

Life of this patent

Abstract

Claims8